Related Experiment Video

Updated: Jun 23, 2026

Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood
11:17

Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood

Published on: October 12, 2012

Enoxaparin in patients with primary percutaneous coronary intervention for acute ST segment elevation myocardial

Arne Kristian Schwarz1, Uwe Zeymer

  • 1Herzzentrum Ludwigshafen, Medizinische Klinik B, Ludwigshafen, Germany. schwarak@klilu.de

Future Cardiology
|April 18, 2009
PubMed

Insights

Enoxaparin may reduce death and reinfarction in ST-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention. This anticoagulation therapy shows promise without increasing bleeding risks, warranting further large-scale trials.

Area of Science:

  • Cardiology
  • Pharmacology
  • Interventional Cardiology

Background:

  • Thrombin inhibition is crucial in managing ST-elevation myocardial infarction (STEMI) during primary percutaneous coronary intervention (PCI).
  • Enoxaparin offers more predictable anticoagulation than unfractionated heparin.
  • Existing data suggest potential benefits of enoxaparin in STEMI patients undergoing primary PCI.

Purpose of the Study:

  • To evaluate the efficacy and safety of enoxaparin as an adjunct therapy in primary PCI for STEMI.
  • To compare enoxaparin with unfractionated heparin in this patient population.

Main Methods:

  • Review of smaller studies and prospective registries.
  • Analysis of outcomes including death, nonfatal reinfarction, and bleeding complications.

Main Results:

  • Enoxaparin is associated with reduced rates of death and nonfatal reinfarction post-primary PCI.
  • No significant increase in bleeding complications was observed with enoxaparin.

Conclusions:

  • Enoxaparin demonstrates potential as a safe and effective anticoagulant in STEMI patients undergoing primary PCI.
  • A large randomized trial is recommended to confirm these findings and establish enoxaparin's role.

Related Concept Videos

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Acute Coronary Syndrome V: Nursing Management01:26

Acute Coronary Syndrome V: Nursing Management

Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...